Glucolipid Mixture Composition for Foam Stabilization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing bio-based surfactant formulations, such as those containing di-rhamnolipids, are complex and have high molecular weights, limiting their simplicity and effectiveness in foam stabilization and skin compatibility.

Innovation Solution

A mixture composition comprising glucolipids in defined weight ratios, specifically including glucolipids like GL-C10C10, GL-C8C10, and GL-C10C12, which provide excellent foam stability, volume, and skin compatibility, while being simpler in structure and lower in molecular weight.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If di-rhamnolipids are used for foam stabilization, then foam stability is improved, but molecular weight increases and structural complexity increases

Engineering Contradiction:
Improvefoam stabilityVSAvoidstructural complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent segments the complex di-rhamnolipid structure into simpler glucolipid building blocks (monoacylglycerols with glucose heads) that can be produced more simply while maintaining foam stabilization functionality. The mixture of different chain length glucolipids (C8, C10, C12) provides the necessary complexity for effective foam stabilization without requiring the high molecular weight of di-rhamnolipids.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent changes key parameters including molecular weight (reducing from di-rhamnolipid to glucolipid), chain length distribution (using C8-C12), and head group structure (using glucose instead of rhamnose). These parameter changes enable simpler production while maintaining or improving foam stability through optimized surface activity.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If di-rhamnolipids are used for foam stabilization, then foam stability is improved, but production yield decreases

Engineering Contradiction:
Improvefoam stabilityVSAvoidproduction yield
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent employs Pseudomonas putida bacteria that naturally produce glucolipids as part of their metabolic process. The bacteria utilize readily available substrates (glucose, fatty acids) to self-produce the surfactant, eliminating complex multi-step chemical synthesis and achieving high production yields through biological self-service.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent replaces complex chemical synthesis mechanisms with biological production mechanisms. Instead of multi-step chemical reactions requiring strict control conditions, the system uses bacterial metabolism which operates under milder conditions and achieves higher yields through natural catalytic pathways.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The glucolipid mixture composition achieves superior foam stability and volume under aqueous conditions, with enhanced skin compatibility and mildness, allowing for effective washing and leaving a soft skin feel, and can be synthesized with higher yields and concentrations than di-rhamnolipids.

Implementation Method 1

The glucolipid mixture composition achieves superior foam stability and volume under aqueous conditions

Methodology Applied
Scientific EffectSurface tension reduction: Surface Tension

Implementation Method 2

excellent foam stability under aqueous conditions; outstanding foam volume under aqueous conditions; exceptional foaming behavior

Methodology Applied
Scientific EffectFoam formation: Foam

Data Source

PatentUS11993803B2Mixture composition comprising glucolipids
Publication Date: 2024.05.28 EVONIK OPERATIONS GMBH
  • US11993803B2 patent drawing
  • US11993803B2 patent drawing
  • US11993803B2 patent drawing

AI summary

The invention relates to a mixture composition comprising glucolipids, to its use for producing formulations and to formulations comprising this mixture composition.